Company Filing History:
2 out of 215 
2 out of 1,001 
2 out of 1,858 
Years Active: 1989-2023
Title: Shuh Narumiya: A Pioneer in Immunology and Molecular Biology
Introduction
Shuh Narumiya is a distinguished inventor based in Kyoto, Japan, known for his significant contributions to the fields of immunology and molecular biology. With a total of eight patents to his name, Narumiya has made remarkable advancements in understanding and manipulating T cells, which play a crucial role in the immune system.
Latest Patents
Among his latest patents is a novel compound and method for producing regulatory T cells. This invention provides a compound that exhibits CDK8 and/or CDK19 inhibitory activity, which is essential for inducing Foxp3 in T cells. The treatment of T cells with this inhibitor can lead to the induction of Foxp3T cells in vitro, thereby facilitating the generation of regulatory T cells. Another significant patent involves a Rho target protein derived from humans, along with the gene encoding it. This invention aims to provide an activated Rho protein that has specific binding activities and can be utilized in diagnosing conditions such as respiratory tract hypersensitivity, bronchial asthma, acute myelocytic leukemia, and myelodysplasia syndrome.
Career Highlights
Shuh Narumiya has worked with notable companies, including Kirin Beer and Shionogi & Company Limited. His work in these organizations has contributed to his expertise and innovation in the field of molecular biology.
Collaborations
Throughout his career, Narumiya has collaborated with esteemed colleagues such as Toru Kita and Masayuki Narisada. These collaborations have further enriched his research and development efforts.
Conclusion
Shuh Narumiya's innovative work in the field of immunology, particularly in the development of regulatory T cells and Rho proteins, showcases his dedication to advancing medical science. His contributions continue to have a lasting impact on the understanding and treatment of various diseases.